- CCR6-CCL20 axis as a therapeutic target for autoimmune diseases
Heikrujam Thoihen Meitei et al, 2021, Autoimmunity Reviews CrossRef - Small molecule inhibitors of RORĪ³t for Th17 regulation in inflammatory and autoimmune diseases
Jiuping Zeng et al, 2023, Journal of Pharmaceutical Analysis CrossRef - The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis
Keiichi Uchida et al, 2015, Gastroenterology Research and Practice CrossRef - Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance
Neeraja Kulkarni et al, 2017, Journal of Leukocyte Biology CrossRef - VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease
Leo R. Fitzpatrick et al, 2020, Inflammopharmacology CrossRef - SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation
David N. Hanna et al, 2022, Gastroenterology CrossRef - The involvement of TH17 cells in the pathogenesis of IBD
Ping Jiang et al, 2023, Cytokine & Growth Factor Reviews CrossRef - Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells
Rocco Spagnuolo et al, 2018, Inflammatory Bowel Diseases CrossRef - The crucial role of fish mucus in regulating progeny inflammation and microbial homeostasis
Zi-Xuan Wang et al, 2024, Water Biology and Security CrossRef